Suchergebnisse - "Hu, Ruozhen"

PubPharm (42)

1

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

enthalten in: Nature | 2024

von Guan, X. | Hu, R. | Choi, Y. | +28

ErratumIn: Nature. 2024 Mar 13;:. - PMID 38480897

2

Publisher Correction : Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

enthalten in: Nature | 2024

von Guan, X. | Hu, R. | Choi, Y. | +28

ErratumFor: Nature. 2024 Mar;627(8004):646-655. - PMID 38418879

3

Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer

enthalten in: Cell reports. Medicine | 2024

von Galsky, M. | Guan, X. | Rishipathak, D. | +30

4

Imidazolone as an Amide Bioisostere in the Development of β-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors

enthalten in: Journal of medicinal chemistry | 2023

von Jackson, J. | Siegmund, A. | Bai, W. | +14

5

Impaired emotion perception in schizophrenia shows sex differences with channel- and category-specific effects : A pilot study

enthalten in: Journal of psychiatric research | 2023

von Lin, Y. | Li, C. | Hu, R. | +4

6

MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during Neuroinflammation

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2023

von Thompson, J. | Hu, R. | Huffaker, T. | +8

7

INHIBITIONS OF SIRP-GAMMA FOR CANCER TREATMENT

enthalten in: Europäisches Patentamt | 2022

von HU RUOZHEN | MANZANILLO PAOLO | OUYANG WENJUN

8

INHIBITION OF SIRP-GAMMA FOR CANCER TREATMENT

enthalten in: Europäisches Patentamt | 2022

von HU RUOZHEN | MANZANILLO PAOLO | OUYANG WENJUN

9

Inhibition of SIRP-gamma for cancer treatment

enthalten in: Europäisches Patentamt | 2021

von HU RUOZHEN | MANZANILLO PAOLO | OUYANG WENJUN

10

Inhibition of SIRP-gamma for cancer treatment

enthalten in: Europäisches Patentamt | 2021

von HU RUOZHEN | MANZANILLO PAOLO | OUYANG WENJUN

1
2
3
4
5
Nächster »
[5]